Antithrombotic therapy in valvular heart disease

Chest

Volumn 108, Issue 4 SUPPL., 1995, Pages 360S-370S

  Levine, H J ^a   Pauker, S G ^a   Eckman, M H ^a  

^a Box 315 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

AORTA VALVE DISEASE; BACTERIAL ENDOCARDITIS; BLEEDING; CONFERENCE PAPER; DISEASE SEVERITY; HEART ATRIUM SEPTUM DEFECT; HUMAN; MITRAL VALVE PROLAPSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; THROMBOSIS PREVENTION; VALVULAR HEART DISEASE;

EID: 0028783327     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.108.4_Supplement.360S     Document Type: Conference Paper

References (137)

1. Rahimtoola SH. Valvular heart disease: a perspective J Am Coll Cardiol 1 1983 199 215
2. Edmunds LH Jr. Thrombotic complications of current valvular prostheses Ann Thorac Surg 34 1982 96 106
3. Roy D Marchand E Gagne P Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation Am Heart J 112 1986 1039 1043
4. Cannegieter SC Rosendaal FR Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses Circulation 89 1994 635 641
5. Hull R Hirsh J Jay C Different intensities of anticoagulation in the long term treatment of proximal vein thrombosis N Engl J Med 307 1982 1676 1681
6. Turpie ACG Gunstensen J Hirsh J Randomized comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement Lancet 1 1988 1242 1245
7. Saour JN Sieck JO Mamo LAR Trial of different intensities of anticoagulation in patients with prosthetic heart valves N Engl J Med 322 1990 428 432
8. Altman R Rouvier J Gurfinkel E Comparison of two levels of anticoagulant therapy in patients with substitute heart valves J Thorac Cardiovasc Surg 101 1991 427 431
9. Petersen P Boysen G Godtfredsen T Placebo controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation Lancet 1 1989 175 179
10. Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the stroke prevention in atrial fibrillation study. N Engl J Med 1990; 322:863-8
11. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990; 323:1505-11
12. Connolly SJ Laupacis A Gent M Canadian atrial fibrillation anticoagulation (CAFA) study J Am Coll Cardiol 18 1991 349 355
13. Ezekowitz MD Bridgers SL James KE Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation N Engl J Med 327 1992 1406 1412
14. Wood P. Diseases of the heart and circulation 1956 JB Lippincott Philadelphia
15. Ellis LB Harken DE. Arterial embolization in relation to mitral valvuloplasty Am Heart J 62 1961 611 620
16. Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease BMJ 1 1964 209 212
17. Dervall PB Olley PM Smith DR Incidence of stenosis embolism before and after mitral valvotomy Thorax 23 1968 530 540
18. Levine HJ. Which atrial fibrillation patients should be on chronic anticoagulation? J Cardiovasc Med 6 1981 483 487
19. Hinton RC Kistler JP Fallon JJ Influence of etiology of atrial fibrillation on incidence of systemic embolism Am J Cardiol 40 1977 509 513
20. Harris AW Levine SA. Cerebral emboli in mitral stenosis Ann Intern Med 15 1941 637 643
21. Coulshed N Epstein EJ McKendrick CS Systemic embolism in mitral valve disease Br Heart J 32 1970 26 34
22. Cassella K Abelmann WH Ellis LB. Patients with mitral stenosis and systemic emboli Arch Intern Med 114 1964 773
23. Dewar HA Weightman D. Study of embolism in mitral valve disease and atrial fibrillation Br Heart J 49 1983 133 140
24. Hay WE Levine SA. Age and atrial fibrillation as independent factors in auricular mural thrombus formation Am Heart J 24 1942 1 4
25. Daley R Mattingly TW Holt C Systemic arterial embolism in rheumatic heart disease Am Heart J 42 1951 566 581
26. Fleming HA Bailey SM. Mitral valve disease, systemic embolism and anticoagulants Postgrad Med J 47 1971 599 604
27. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II Echocardiographic features of patients at risk. Ann Intern Med 1992; 116:6-12
28. Caplan LR D'Cruz I Hier DB Atrial size, atrial fibrillation and stroke Ann Neurol 19 1986 158 161
29. Mounier-Vehier F Leys D Rondepierre P Silent infarcts in patients with ischemic stroke are related to age and size of the left atrium Stroke 24 1993 1347 1351
30. Friedberg CK. Diseases of the heart 3rd ed. 1966 WB Saunders Philadelphia
31. Carter AB. Prognosis of cerebral embolism Lancet 2 1965 514 519
32. Adams GF Merrett JD Hutchinson WM Cerebral embolism and mitral stenosis: survival with and without anticoagulants J Neurol Neurosurg Psychiatry 37 1974 378 383
33. Pumphry CW Fuster V Cheseboro HJ. Systemic thromboembolism in valvular heart disease and prosthetic heart valves Mod Concepts Cardiovasc Dis 51 1982 131 136
34. Grim RA Stewart WJ Black IW Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation? J Am Coll Card 23 1994 533 541
35. Black IW Fatkin D Sagar KB Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after conversion of atrial fibrillation Circulation 89 1994 2509 2513
36. Weily HS Genton E. Altered platelet function in patients with prosthetic mitral valves: effect of sulfinpyrazone therapy Circulation 42 1970 967 972
37. Harker LA Slichter SJ. Platelet and fibrinogen consumption in man N Engl J Med 287 1972 999 1005
38. Weily HS Steele DP Davies H Platelet survival in patients with substitute heart valves N Engl J Med 290 1974 534 537
39. Taguchi K Matsumara H Washizu T Effect of athrombogenic therapy, especially high dose therapy of dipyridamole after prosthetic valve replacement J Cardiovasc Surg 16 1975 8 15
40. Steele PP Weily HS Davis H Platelet survival in patients with rheumatic heart disease N Engl J Med 290 1974 537 539
41. Steele P Rainwater J. Favorable effect of sulfinpyrazone in thromboembolism in patients with rheumatic heart disease Circulation 62 1980 462 465
42. Goodnight SH. Antiplatelet therapy for mitral stenosis? [editorial] Circulation 62 1980 466 468
43. Harker LA Slichter SJ Sauvage LR. Platelet consumption by arterial prostheses: the effects of endothelization and pharmacologic inhibition of platelet function Ann Surg 186 1997 594 601
44. Sullivan JM Harken DE Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement N Engl J Med 284 1971 1391 1394
45. Cheseboro JH Fuster V McGoon DC Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared to dipyridamole Am J Cardiol 51 1983 1537 1541
46. Dale J Myhre E Stortstein O Prevention of arterial thromboembolism with acetylsalicylic acid; a controlled clinical study in patients with aortic ball valves Am Heart J 94 1977 101 111
47. Turpie AGG Gent M Laupacis A A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement N Engl J Med 329 1993 524 529
48. Hayashi J Nakazawa S Oguma F Combined warfarin and antiplatelet therapy after St. Jude's Medical Valve replacement for mitral valve disease J Am Coll Cardiol 23 1994 672 677
49. Fitzgerald GA. Dipyridamole N Engl J Med 316 1987 1247 1257
50. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study. Lancet 1994; 343:687-91
51. Albers GW. Atrial fibrillation and stroke: three new studies, three remaining questions Arch Intern Med 154 1994 1443 1448
52. Eckman MH Levine HJ Pauker SG. Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues Chest 108 1995 457S 470S
53. Jeresaty RM. Mitral valve prolapse 1979 Raven Press New York
54. Barnett HJM. Transient cerebral ischemia: pathogenesis, prognosis, and management Ann R Coll Physicians Surg Can 7 1974 153 173
55. Barnett HJM Jones ME Boughner DR Cerebral ischemic events associated with prolapsing mitral valve Arch Neurol 33 1976 777 782
56. Hirsowitz GS Saffer D. Hemiplegia and the billowing mitral leaflet syndrome J Neurol Neurosurg Psychiatry 41 1978 381 383
57. Saffro R Talano JV. Transient ischemic attack associated with mitral systolic clicks Arch Intern Med 139 1979 693 694
58. Hanson MR Hodgman JR Conomy JP. A study of stroke associated with prolapsed mitral valve Neurology 23 1978 341
59. Barnett HJM Boughner DR Taylow DW. Further evidence relating mitral valve prolapse to cerebral ischemic events N Engl J Med 302 1980 139 144
60. Gilon D Buonanno FS Kistler JP Mitral valve prolapse: is it associated with acute ischemic neurologic events? [abstract] J Am Coll Cardiol 33A 1995
61. Pomerance A. Balloon deformity (mucoid degeneration) of atrioventricular valves Br Heart J 31 1969 343 351
62. Guthrie RB Edwards JE. Pathology of myxomatous mitral valve: nature, secondary changes and complications Minn Med 59 1976 637 647
63. Kostuk WJ Barnett HJM Silver MD. Strokes: a complication of mitral-leaflet prolapse? Lancet 2 1977 313 316
64. Geyer SJ Franzini DA. Myxomatous degeneration of the mitral valve complicated by nonbacterial thrombotic endocarditis with systemic embolization Am J Clin Pathol 72 1979 489 492
65. Turgan SK Mau RD Schwartz MJ. Anterior myocardial infarction patterns in the mitral valve prolapse-systolic click syndrome Am J Med 58 1975 719 723
66. Hart RG Easton JD. Mitral valve prolapse and cerebral infarction Stroke 13 1982 429 430
67. Cheitlin MD. Thromboembolic studies in the patient with the prolapsed mitral valve: has Salome dropped another veil? [editorial] Circulation 60 1979 46 47
68. Barnett HJM McDonald JWD Sackett DL. Aspirin: effective in males threatened with stroke Stroke 9 1978 295 297
69. Steele P Weily H Rainwater J Platelet survival time and thromboembolism in patients with mitral valve prolapse Circulation 60 1979 43 45
70. Levine HJ Isner JM Salem DN. Primary vs secondary mitral valve prolapse: clinical features and implications Clin Cardiol 5 1982 371 375
71. Jackson AC Boughner DR Barnett JHM. Mitral valve prolapse and cerebral ischemic events in young people Neurology 34 1984 784 787
72. Nishimura RA McGoon MD Shub C Echocardiographically documented mitral valve prolapse: long-term follow up of 237 patients N Engl J Med 313 1985 1305 1309
73. Marks AR Choong CY Sanfilippo AJ Identification of high-risk and low-risk subgroups of patients with mitral valve prolapse N Engl J Med 320 1989 1031 1036
74. Korn D DeSanctis RW Sell S. Massive calcification of the mitral annulus N Engl J Med 268 1962 900 909
75. Guthrie JJ Fairgrieve JJ. Aortic embolism due to a myxoid tumor associated with myocardial calcification Br Heart J 25 1963 137 140
76. Fulkerson PK Beaver BM Auseon J Calcification of the mitral annulus: etiology, clinical associations, complications and therapy Am J Med 66 1979 967 977
77. Kalman P DePace NL Kotler MN Mitral annular calcification and echogenic densities in the left ventricular outflow tract in association with cerebral ischemic events J Cardiovasc Ultrasonog 1 1982 155
78. Nestico PDF DePace NL Morganroth J Mitral annular calcification: clinical pathophysiology and echocardiographic review Am Heart J 107 1984 989 996
79. Benjamin EJ Plehn JF D'Agostino RB Mitral annular calcification and the risk of stroke in an elderly cohort N Engl J Med 327 1992 374 379
80. Kirk RS Russell JGB. Subvalvular calcification of mitral valve Br Heart J 31 1969 684 692
81. Ridolfi RL Hutchins GM. Spontaneous calcific emboli from calcific mitral annulus fibrosus Arch Pathol Lab Med 100 1976 117 120
82. Brockmeier LB Adolph RJ Gustin BW Calcium emboli to the retinal artery in calcific aortic stenosis Am Heart J 101 1981 32 37
83. Savage DD Garrison RJ Castelli WP Prevalence of submitral (annular) calcium and its correlations in a general population-based sample (the Framingham Study) Am J Cardiol 51 1983 1375 1378
84. Stein P Sabbath H Apitha J. Continuing disease process of calcific aortic stenosis Am J Cardiol 39 1977 159 163
85. Pleet AB Massey EW Vengrow MR. TIA, stroke and the bicuspid aortic valve Neurology 31 1982 1540
86. Holley KE Bahn RC McGoon DC Spontaneous calcification associated with calcific aortic stenosis Circulation 27 1963 197 202
87. Daley R Mattingly TW Holt C Systemic arterial embolism in rheumatic heart disease Am Heart J 42 1951 566 581
88. Myler RK Sanders CA. Aortic valve disease and atrial fibrillation: report of 122 patients with electrocardiographic, radiographic and hemodynamic observations Arch Intern Med 121 1968 530
89. Schneider B Hanrath P Vogel P Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebral events J Am Coll Cardiol 16 1990 1000 1009
90. Thompson T Evans W. Paradoxical embolism Q J Med 23 1930 135 150
91. Hagen PT Scholtz DG Edwards WD. Incidence and size of patent foramen ovale during the first 10 years of life: an autopsy study of 965 normal hearts Mayo Clinic Proc 59 1984 17 20
92. Lynch JJ Schuchand GH Gross CM Prevalence of right-to-left shunting in the healthy population: detection by Valsalva maneuver contrast echocardiography Am J Cardiol 53 1984 1478 1480
93. Lechat PH Mas JL Lascault G Prevalence of patent foramen ovale in patients with stroke N Engl J Med 318 1988 1148 1152
94. Stollberger C Slany J Schuster I The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism Ann Intern Med 119 1993 461 465
95. Webster MWI Chancellor AM Smith HJ Patent foramen ovale in young stroke patients Lancet 2 1988 11 12
96. DiTullio M Sacco RL Gopal A Patent foramen ovale as a risk factor for cryptogenic stroke Ann Intern Med 117 1992 461 465
97. DeBelder MA Tourikis L Leech G Risk of patent foramen ovale for thromboembolic events in all age groups Am J Cardiol 69 1992 1316 1320
98. Movsowitz C Podolsky LA Meyerowitz CB Patent foramen ovale: a nonfunctional embryological remnant or a potential cause of significant pathology? J Am Soc Echocardiogr 5 1992 257 270
99. Pearson AC Nagelhout D Castello R Atrial septal aneurysm and stroke: a transesophageal echocardiographic study J Am Coll Cardiol 18 1991 1223 1229
100. Weinstein L. Infective endocarditis Braunwald E Heart disease 1984 WB Saunders Philadelphia
101. Cates JE Christie RV. Subacute bacterial endocarditis: a review of 442 patients treated in 14 centers appointed by the penicillin trials committee of the MRC Q J Med 20 1951 93
102. Brunson JG. Coronary embolism in bacterial endocarditis Am J Pathol 26 1953 689
103. Lerner PI Weinstein L. Infective endocarditis in the antibiotic era N Engl J Med 274 1966 323 393
104. Pruitt AA Rubin RH Karchmer AW Neurologic complications of bacterial endocarditis Medicine 57 1978 329 343
105. Carpenter JL McAllister CK. Anticoagulation in prosthetic valve endocarditis South Med J 76 1983 1372 1375
106. Garvey CJ Neu HC. Infective endocarditis: an evolving disease Medicine 57 1979 105 126
107. Morgan WL Bland EF. Bacterial endocarditis in the antibiotic era Circulation 19 1959 753 759
108. Ginzton LE Siegel RJ Criley JM. Natural history of tricuspid valve endocarditis: a two-dimensional echocardiographic study Am J Cardiol 49 1982 1853 1859
109. Friedman M Katz LN Howell K. Experimental endocarditis due to streptococcal viridans Arch Intern Med 61 1938 95
110. Loewe L Rosenblatt P Greene HJ Combined penicillin and heparin therapy of subacute bacterial endocarditis JAMA 124 1944 144 149
111. Thill CJ Meyer OO. Experiences with penicillin and dicoumarol in the treatment of subacute bacterial endocarditis Am J Med Sci 213 1947 300
112. McLean J Meyer BBM Griffith JM. Heparin in subacute bacterial endocarditis: report of a case and critical review of literature JAMA 117 1941 1870 1879
113. Katz LN Elek SR. Combined heparin and chemotherapy in subacute bacterial endocarditis JAMA 124 1944 149 152
114. Kanis JA. The use of anticoagulants in bacterial endocarditis Postgrad Med J 50 1974 312 313
115. Finland M. Current status of therapy in bacterial endocarditis JAMA 166 1959 364 373
116. Priest WS Smith JM McGee CJ. The effect of anticoagulants on the penicillin therapy and the pathologic lesion of subacute bacterial endocarditis N Engl J Med 235 1946 699 706
117. Wann LS Dillon JC Weyman AE Echocardiography in bacterial endocarditis N Engl J Med 295 1976 135
118. Roy P Tajik AJ Guiliani ER Spectrum of echocardiographic findings in bacterial endocarditis Circulation 53 1976 474 482
119. Stuart JA Silimperi D Harris P Echocardiographic documentation of vegetative lesion in infective endocarditis: clinical implications Circulation 61 1980 374 380
120. O'Brien JT Geiser EA. Infective endocarditis and echocardiography Am Heart J 108 1984 386 394
121. Popp RL. Echocardiography N Engl J Med 323 1990 165 172
122. Paschalis C Pugsley W John R Rate of cerebral embolic events in relation to antibiotic and anticoagulant therapy in patients with bacterial endocarditis Eur Neurol 30 1990 87 89
123. Block PC DeSanctis RW Weinberg AN. Prosthetic valve endocarditis J Thorac Cardiovasc Surg 60 1970 540 548
124. Wilson WR Geraci JE Danielson GK Anticoagulant therapy and central nervous system complications in patients with prosthetic valve endocarditis Circulation 57 1978 1004 1007
125. Yeh TJ Anabtaw I Cornet VE Influence of rhythm and anticoagulation upon the essence of embolization associated with Starr-Edwards prostheses Circulation 35 1967 77 81
126. Johnson WD Jr. Prosthetic valve endocarditis Kay E Infective endocarditis 1979 University Park Press Baltimore 129
127. Lieberman A Hass WE Pinto R Intracranial hemorrhage and infarction in anticoagulated patients with prosthetic heart valves Stroke 9 1978 18 24
128. Scott WR New PFJ Davis KR Computerized axial tomography of intracerebral and intraventricular hemorrhage Radiology 112 1974 73 80
129. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: a randomized trial. Stroke 1983; 14:668-76
130. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Stroke 1984; 15:779-89
131. Cohn LH Mudge GH Pratter F Five to eight year follow-up of patients undergoing porcine heart valve replacement N Engl J Med 304 1982 258 262
132. Davenport J Hart RG. Prosthetic valve endocarditis 1976–87: antibiotics, anticoagulation and stroke Stroke 21 1990 993 999
133. Lopez JA Ross RS Fishbein MC Non-bacterial thrombotic endocarditis: a review Am Heart J 113 1987 773 784
134. Angrist A Marquiss J. The changing morphologic picture of endocarditis since the advent of chemotherapy and antibiotic agents Am J Pathol 30 1954 39 63
135. Sack GH Levin J Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic and therapeutic features Medicine 56 1977 1 37
136. Rogers LR Cho ES Kempin S Cerebral infarction from non-bacterial thrombotic endocarditis: clinical and pathological study including the effects of anticoagulation Am J Med 83 1987 746 756
137. Lopez JA Fishbein MC Siegel RJ. Echocardiographic features of non-bacterial thrombotic endocarditis Am J Cardiol 59 1987 478 480